Current and future uses of biological response modifiers in the treatment of viral hepatitis.
Van Thiel
D H
DH
Oklahoma Transplantation Institute, Baptist Medical Center of Oklahoma, Oklahoma City 73112.
D002986:Clinical Trials as Topic; D006509:Hepatitis B / Q000628:therapy*; D006526:Hepatitis C / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*
D007155:Immunologic Factors